{
Ypsomed Holding AG

Companies

}
001122334455554433221100
001122334455554433221100

Swiss stock market rises as Kühne Nagel and UBS lead gains

The Swiss stock market closed higher on Monday, with the SMI index surpassing 12,000 points for the first time since late October, despite a cautious trading environment ahead of Donald Trump's inauguration. Kühne + Nagel, Lonza, and UBS were among the top gainers, while Zurich and Schindler saw declines. The VSMI volatility index rose by 6.5%, indicating expectations of increased market fluctuations.
Finanz und Wirtschaft
United States Dollar Meyer Burger Technology AG Ypsomed Holding AG Schindler Holding AG Nestle SA Swisscom AG Novartis AG Swiss Life Holding AG Hoffmann-La Roche AG Sika AG SGS SA Zurich, Agence générale Christian Meier SA INFICON Holding AG Lonza Group AG Kuehne + Nagel International AG Peach Property ANR BELIMO Holding AG Swiss Re AG CHE Show more
Finance & Economy, Market Report
08:04 20.01.2025

swiss stock exchange declines as investors react to economic uncertainties

The Swiss stock exchange closed lower, with the SMI down 0.26% at 11,384.92 points, marking a 3% loss over the week and reducing year-to-date gains to just 2%. Investor uncertainty stems from the Federal Reserve's cautious approach to interest rate cuts and concerns over a potential U.S. government shutdown. Notable declines were seen in UBS, Partners Group, and various insurance companies, while Idorsia plummeted 50.35% due to delays in drug negotiations.
SWI swissinfo.ch
Swiss Franc United States Dollar Hoffmann-La Roche AG S Tempo Swiss Life AM Novo Nordisk A/S Axon Partners Group, S.A. ABB Ltd Holcim AG Nestlé S.A. Zurich, Agence générale Christian Meier SA Ypsomed Holding AG Novartis AG Credit Suisse Real Estate Fund Siat Sika AG Swiss Re AG Idorsia Ltd Geberit AG CHE Show more
Finance & Economy, Market Report
17:45 20.12.2024

UBS maintains buy rating for Gerresheimer with target price of 132 euros

UBS has maintained a "Buy" rating for Gerresheimer, setting a target price of 132 euros. Analyst Olivier Calvet highlighted that data on Novo Nordisk's weight-loss drug CagriSema could significantly impact Gerresheimer, positioning it favorably against competitors like Ypsomed.
boerse.de
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA I Ypsomed Holding AG DEU Olivier Calvet Show more
TradFi, Market Report
10:48 29.11.2024

ubs maintains buy rating on gerresheimer with target of 132 euros

UBS has maintained a Buy recommendation for Gerresheimer, setting a price target of 132 euros. Analyst Olivier Calvet notes that data from the study on Novo Nordisk's weight-lowering drug CagriSema could significantly impact the company's stock, as Gerresheimer is a key supplier.
Zonebourse
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA I Ypsomed Holding AG DEU Olivier Calvet Show more
TradFi, Market Report
09:48 29.11.2024

ubs maintains buy rating for gerresheimer with target price of 132 euros

UBS has maintained a "Buy" rating for Gerresheimer, setting a target price of 132 euros. Analyst Olivier Calvet highlighted that data from Novo Nordisk's weight-loss drug CagriSema could significantly impact Gerresheimer, positioning it favorably against competitors like Ypsomed.
@borsen_news
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA I Ypsomed Holding AG DEU Olivier Calvet Show more
TradFi, Market Report
08:49 29.11.2024

ubs maintains buy rating for gerresheimer with target price of 132 euros

UBS has maintained its "Buy" rating for Gerresheimer, setting a target price of 132 euros. Analyst Olivier Calvet noted that study data on Novo Nordisk's weight-loss drug CagriSema could significantly impact Gerresheimer, positioning it favorably against competitors like Ypsomed.
boerse.de
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA I Ypsomed Holding AG CHE Olivier Calvet Show more
TradFi, Market Report
08:04 29.11.2024

ubs maintains buy rating for gerresheimer with target price of 132 euros

UBS has maintained a 'Buy' rating for Gerresheimer, setting a target price of 132 euros. Analyst Olivier Calvet noted that data from Novo Nordisk's weight-lowering drug CagriSema could positively impact Gerresheimer, positioning it favorably compared to Ypsomed. Schott Pharma and Stevanto remain unaffected.
MarketScreener
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA Ypsomed Holding AG DEU Olivier Calvet Show more
TradFi, Market Report
07:51 29.11.2024

ubs upgrades gerresheimer to buy with target price of 132 euros

UBS has upgraded Gerresheimer to a 'Buy' rating with a target price of 132 euros. Analyst Olivier Calvet noted that data from Novo Nordisk's weight-lowering drug CagriSema could significantly impact Gerresheimer, positioning it favorably compared to competitors like Ypsomed.
aktiencheck.de
Euro Gerresheimer AG Stevanto UBS Novo Nordisk A/S SCHOTT Pharma AG & Co. KGaA Ypsomed Holding AG CHE Olivier Calvet Show more
TradFi, Market Report
07:04 29.11.2024

swiss small and mid caps show resilience amid economic challenges

Swiss small and mid-cap companies present intriguing opportunities for portfolio diversification, particularly in sectors like medtech, which has outpaced the Swiss economy with 6% growth over the past decade. While some sectors face challenges, such as food and automotive, others, especially those linked to artificial intelligence and pharmaceuticals, are thriving. Current valuations in this segment are below historical averages, indicating potential for growth despite a seemingly unfavorable environment.
Allnews
Swiss Franc Siegfried Holding AG Bachem Holding AG Ypsomed Holding AG BELIMO Holding AG Huber+Suhner AG Straumann Holding AG DEU CHE CHN Show more
TradFi, Market Report
07:00 14.11.2024
Trending
Subcategory
Industry Trends Corporate News Startups & Entrepreneurship Global Trade Developments Retail and Consumer Goods Supply Chain Management Stock Market Updates Government Economic Policies Private Equity Deals Energy Sector Developments Industry Mergers & Acquisitions AI Applications Funding Rounds & Investments AI Innovations Fintech Startups Venture Capital Investments Emerging Startups IPOs & SPACs CEO Changes Inflation and Monetary Impact
Countries:
USA CHN IND JPN ARE SAU KOR SGP TWN VNM CAN THA GBR IDN TUR MYS DEU AUS ISR NZL
Companies:
Apple Inc. Google Inc. Tesmec S.p.A. Amazon.com, Inc. Microsoft Corporation Mastercard Inc NVIDIA Corp Tesla, Inc. OpenAI ERC USD The Goldman Sachs Group, Inc. Visa Inc. SWIGGY LIMITED GLOE Inc. Ripple USD USD OLA ELECTRIC MOBILITY LTD Microsoft Corp Micron Technology, Inc. SAP SE Oracle Corp Ather Energy Ltd.
Currencies:
United States Dollar Indian Rupee Chinese Yuan Euro Japanese Yen British Pound Sterling Saudi Riyal United Arab Emirates Dirham New Zealand Dollar Thai Baht Vietnamese Đồng Canadian Dollar Indonesian Rupiah South Korean Won Malaysian Ringgit Brazilian Real Swiss Franc Qatari Riyal Bangladeshi Taka Kuwaiti Dinar
People:
Donald Trump Scott Bessent Joe Biden Mohammed bin Salman Al Saud Nikolay Storonsky Ye Lin Imad Boumahdi Afeef Zaman Elon Musk Mark Carney Sri Mulyani Brad Garlinghouse Ryan Fugger Paetongtarn Shinawatra Tomasz Tunguz Jake Saper Howard Lutnick Ronald Reagan George Kurtz Anthony Casalena

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Links

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Save settings
Reset settings
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.